FTO and acute myeloid leukemia: To date, m6A writers (METTL3, METTL14, WTAP), erasers (FTO, ALKBH5), and readers (YTHDF2, YTHDC1, IGF2BP1) are considered oncogenic proteins in AML and are responsible for the maintenance of LSCs.